Vural Yilmaz
AMR, or active and persistent antibody-mediated rejection, is a frequent reason for graft failure. The prognostic indicators for this condition are unclear. Our goal was to identify the demographic, histological and clinical characteristics of transplant recipients who had AMR and to assess how these traits and antirejection therapy options affected graft survival.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 